Hashimoto's and Perimenopause: Why Symptoms Overlap (and How to Tell Them Apart)

I was diagnosed with Hashimoto's at 32. By 44, I had a stable levothyroxine dose, decent labs, and a life that worked. Then somewhere around 45 the wheels came off. Brain fog so dense I couldn't remember why I'd opened the fridge. Weight that wouldn't budge. Hair in the shower drain again. My endocrinologist ran a TSH, said it was “in range,” and shrugged.

It took eighteen months and three doctors to discover that I was also in perimenopause — and that the two were feeding each other.

Why Hashimoto's and perimenopause overlap so heavily

Estrogen and thyroid hormone share an intricate relationship. Estrogen increases thyroid-binding globulin (TBG), the protein that ferries thyroid hormone through your blood. When estrogen rises and falls erratically (as it does in perimenopause), TBG levels swing too — which changes how much active, free T3 your tissues actually receive, even if your TSH looks unchanged.

Add in cortisol from disrupted sleep, declining progesterone (which has a calming effect on the immune system), and falling DHEA, and you have a hormonal environment that often pushes Hashimoto's out of remission.

The 14 overlapping symptoms

The labs to ask for (and why your TSH alone is not enough)

Most primary care doctors run only TSH. For women with Hashimoto's in perimenopause, that's like checking the gas gauge of one car to figure out why three cars in the driveway aren't starting. Ask for:

• TSH — the screening test, but it's slow to reflect tissue-level change.
• Free T4 — the storage form of thyroid hormone.
• Free T3 — the active form. Often low-normal in perimenopause even when TSH is fine.
• Reverse T3 — rises under stress and can block T3 receptors.
• TPO and Tg antibodies — to confirm autoimmune activity.
• FSH and estradiol on cycle day 3 — for perimenopause confirmation.
• Vitamin D, ferritin, B12 — deficiencies that mimic both conditions.

What changes about your treatment

1. Levothyroxine dose may need to rise. Studies show 30–40% of Hashimoto's patients require a 12–25% dose increase during perimenopause, especially if they start oral estrogen.
2. Transdermal HRT is usually preferred over oral. Patches and gels bypass the liver and don't raise TBG as much, so your thyroid dose stays more stable.
3. Recheck thyroid 6–8 weeks after any HRT change. Don't wait a year.
4. Address the basics that quiet autoimmunity: sleep, vitamin D level above 50 ng/mL, gluten trial if you haven't, and cortisol pattern testing if morning anxiety is severe.

Is HRT safe with Hashimoto's?

For most women with stable Hashimoto's and no other contraindications, modern transdermal HRT is considered safe by the North American Menopause Society and is often beneficial. The transdermal route avoids the first-pass liver effect that disrupts thyroid binding the most. Compounded estrogen creams and pellets are not recommended; FDA-approved patches, gels, and oral micronized progesterone are.

Your thyroid did not fail you. Your hormones did not fail you. The system failed to look at both at once.

What to bring to your next appointment

1. A 90-day symptom log noting which symptoms cluster pre-period.
2. Your last 3 thyroid panels for trend, not just last value.
3. This list of labs to request.
4. The question: “Are you comfortable managing perimenopause alongside Hashimoto's, or should I see a NAMS-certified practitioner as well?”